NHS Grampian paves way for using AI in lung cancer care across Scotland
By Liz Wells 21 August 2025
NHS Grampian is trialling a process using AI in the detection of lung cancer, which could be embedded in lung cancer care across Scotland.
Lung cancer biomarker testing trial sees drop in deaths
By Liz Wells 10 January 2025
Biomarker testing in individuals at risk of lung cancer led to a major reduction in deaths, new research reveals.
A rising health burden
11 November 2024
Fundamental changes are needed to our health model if the UK is to address Non Communicable Diseases which affect a quarter of the population and cost the country £130bn per year
Director of Families, Quality & Commissioning
£126,543 to £132,441
Lewisham, London (Greater)£126,543 to £132,441
Executive Director of Adult Social Care & Health (DASS)
£166,755 to £173,133
Lewisham, London (Greater)£166,755 to £173,133
Assessor Coach
£31,537- £34,434 pro rata per annum
Northallerton, North Yorkshire£31,537- £34,434 pro rata per annum
Most Read News
Director of Families, Quality & Commissioning
£126,543 to £132,441
Lewisham, London (Greater)£126,543 to £132,441
Executive Director of Adult Social Care & Health (DASS)
£166,755 to £173,133
Lewisham, London (Greater)£166,755 to £173,133
Assessor Coach
£31,537- £34,434 pro rata per annum
Northallerton, North Yorkshire£31,537- £34,434 pro rata per annum
Most Read News
©2024 Hemming Group Limited. Registered in England and Wales. Registered No: 490200. VAT number GB342 023 408
